General Surgical Devices

According to Stratistics MRC, the Global General Surgical Devices Market is accounted for $17.44 billion in 2023 and is expected to reach $34.84 billion by 2030 growing at a CAGR of 10.39% during the forecast period. In the modern healthcare system, general surgical instruments are essential tools that help surgeons execute a variety of tasks quickly and precisely. Devices such as scalpels, forceps, scissors, retractors, and hemostats are included in this category because they are made to make surgical procedures easier. Moreover, with less invasiveness, faster recovery periods, and better patient outcomes, minimally invasive surgical devices, such as robotic-assisted surgical systems and laparoscopic instruments, have been made possible by technological advancements.

According to the American Surgical Association, advancements in surgical techniques and the integration of cutting-edge technologies in general surgical devices have significantly contributed to improving patient outcomes, fostering innovation, and elevating the standards of surgical care across the medical landscape.

Market Dynamics:

Driver:

Growing chronic illness prevalence and aging population

The primary driver of the general surgical device market is the increasing prevalence of chronic diseases, including cancer, cardiovascular disorders, and orthopedic conditions. The probability of individuals needing surgical interventions for age-related health issues is increasing as the world's population ages. The need for general surgical devices is fueled by this shift in the population as well as the prevalence of chronic illnesses. Additionally, these devices can range from conventional instruments to cutting-edge technologies that support complex surgical procedures.

Restraint:

Expensive expenses and financial limitations

The high price of cutting-edge surgical technologies is a major barrier to the market for general surgical devices. For healthcare facilities, the upfront costs associated with acquiring and deploying state-of-the-art equipment, like robotic surgical systems, can be prohibitive. Furthermore, the limited adoption of these technologies due to budgetary constraints in developed and developing regions could potentially hinder the overall growth of the market. To meet this challenge, manufacturers and healthcare providers must strike a balance between cost-effectiveness and innovation.

Opportunity:

Growing requirement for less invasive surgery

The market for general surgical devices is poised for substantial growth due to the growing inclination towards minimally invasive surgical methods. Fewer recovery periods, less pain following surgery, and shorter hospital stays are all advantages of minimally invasive procedures. Moreover, a growing market exists for specialized tools and devices made to facilitate minimally invasive surgeries, which is stimulating innovation and market growth as patient awareness and demand for these procedures increase.

Threat:

Strictly regulated environment

Stricter regulations that may cause delays in the approval of new devices pose a threat to the market for general surgical devices. Manufacturers face difficulties adhering to changing regulatory requirements, which can cause delays in the launch of new products and escalate the expenses related to fulfilling regulatory requirements. Additionally, strict adherence to regulations is necessary to ensure patient safety, but it also poses a risk to the timely release of novel surgical devices.

Covid-19 Impact:

The market for general surgical devices has been severely disrupted by the COVID-19 pandemic, affecting both the supply and demand sides. Especially in the early stages of the pandemic, a decrease in the use of surgical devices resulted from the postponement or cancellation of elective surgeries. Because of the prioritization of COVID-19 cases and the reallocation of resources, healthcare facilities encountered difficulties in continuing their regular operations. Further impeding the market were delays in manufacturing, disruptions in the supply chain, and logistical limitations. However, as healthcare systems adjusted to new standards and the resumption of elective surgeries was prioritized, the later stages of the pandemic saw a slow but steady recovery.

The Laproscopic Devices segment is expected to be the largest during the forecast period

With the largest market share in the general surgical devices market, laparoscopic instruments are essential to minimally invasive surgical treatments. These gadgets include cutting-edge technologies like cameras, insufflators, and specialty tools used in laparoscopic procedures, which minimize patient trauma and allow for smaller incisions. Moreover, laparoscopic device demand has been driven by patients increasing preference for minimally invasive procedures because of their shorter hospital stays, reduced postoperative pain, and faster recovery times. Improved visualization and precision help surgeons perform their jobs more effectively, which benefits patients.

The Neurosurgery segment is expected to have the highest CAGR during the forecast period

With a strong and dynamic trajectory, the neurosurgery segment is expected to have the highest CAGR in the general surgical device market. The need for specialized tools and equipment is driven by the rising incidence of neurological disorders as well as technological developments in neurosurgical techniques and apparatus. The field is expanding quickly due to innovations like robotic-assisted neurosurgery systems, neurostimulation devices, and minimally invasive procedures. Additionally, the need for neurosurgical devices is also fueled by an aging population and increased awareness of neurological disorders.

Region with largest share:

Due to its sophisticated healthcare system, solid regulatory framework, and high incidence of chronic illnesses requiring surgical interventions, North America presently commands the largest market share for general surgical devices. Large investments in R&D, which promote innovation and the adoption of state-of-the-art surgical technologies, are credited with the region's dominance. The widespread use of general surgical devices is facilitated by the existence of major industry participants and a strong reimbursement structure. Furthermore, the aging population and the rising need for minimally invasive surgical procedures are driving the growth of this market in North America.

Region with highest CAGR:

The general surgical devices market is expected to grow at the highest CAGR in the Asia-Pacific region, reflecting the rapidly changing nature of the healthcare system. This remarkable rise is being fueled by a number of factors, including the growing incidence of chronic illnesses, rising healthcare spending, and developing healthcare infrastructure in nations like China and India. Due to the regions large and aging population, there is an increasing need for surgical procedures, which is encouraging the use of cutting-edge general surgical instruments. Additionally, the market is advanced by the emphasis on modernizing healthcare and the integration of cutting-edge technologies.

Key players in the market

Some of the key players in General Surgical Devices market include B. Braun Melsungen AG, Medtronic Plc, Olympus Corporation, 3M Healthcare, Cadence Inc, Boston Scientific Corporation, Cook Medical Inc., Dickinson and Company, Abbott Laboratories, Siemens Healthcare GmbH, Johnson & Johnson Service Inc., Becton, Integra LifeSciences, Conmed Corporation, Hoffmann-La Roche, Stryker Corporation, Erbe Elektromedizin Gmbh, Zimmer Biomet Holdings, Inc. and Teleflex Incorporated.

Key Developments:

In May 2023, Medtronic plc, a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch® device — a tubeless, wearable and fully disposable insulin delivery device. The addition of EOFlow, together with Medtronic's Meal Detection Technology™ algorithm and next-generation continuous glucose monitor (CGM), is expected to expand the company's ability to address the needs of more individuals with diabetes, no matter where they are in their treatment journey or preference for how they want their insulin delivered.

In May 2023, 3M announced it has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. ("Pierrel"), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.

In July 2023, Cadence Design Systems, Inc. and Rambus Inc., a premier chip and silicon IP provider making data faster and safer, today announced that they have entered into a definitive agreement for Cadence to acquire the Rambus SerDes and memory interface PHY IP business. Rambus will retain its digital IP business, including memory and interface controllers and security IP.

Products Covered:
• Electro Surgical Devices
• Handheld Devices
• Laproscopic Devices
• Trocars and Access Devices
• Wound Closure Devices
• Other Products

Types Covered:
• Disposable Surgical Supplies
• Open Surgery Instruments
• Energy-based & Powered Instruments
• Minimally Invasive Surgery Instruments
• Adhesion Prevention Products
• Medical Robotics & Computer Assisted Surgery Devices
• Other Types

Technologies Covered:
• Manual Surgical Equipment
• Wireless Surgical Equipment
• Other Technologies

Applications Covered:
• Orthopedic
• Cardiology
• Ophthalmology
• Wound Care
• Neurosurgery
• Plastic Surgery
• Urology and Gynaecology Surgery
• Other Applications

End Users Covered:
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Academic Institutes
• Research Centers
• Specialty Clinics
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances